Advisor Group Holdings, Inc. Nrx Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.26 - $0.47 $2,632 - $4,758	-10,125 Reduced 91.01%	1,000 $0
Q3 2023 Nov 13, 2023	SELL	$0.23 - $0.5 $3,455 - $7,512	-15,025 Reduced 57.46%	11,125 $2,000
Q2 2023 Aug 10, 2023	SELL	$0.46 - $0.89 $494 - $956	-1,075 Reduced 3.95%	26,150 $12,000
Q4 2022 Feb 10, 2023	BUY	$0.79 - $9.19 $5,269 - $61,297	6,670 Added 32.45%	27,225 $30,000
Q3 2022 Nov 14, 2022	BUY	$0.2 - $8.07 $450 - $18,157	2,250 Added 12.29%	20,555 $15,000
Q2 2022 Aug 10, 2022	BUY	$0.51 - $2.42 $4,653 - $22,082	9,125 Added 99.4%	18,305 $11,000
Q1 2022 May 04, 2022	SELL	$2.45 - $5.04 $82,577 - $169,873	-33,705 Reduced 78.59%	9,180 $22,000
Q3 2021 Nov 05, 2021	BUY	$8.52 - $24.77 $337,221 - $980,396	39,580 Added 1197.58%	42,885 $398,000
Q2 2021 Aug 02, 2021	BUY	$11.62 - $44.5 $38,404 - $147,072	3,305 New	3,305 $38,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $111M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.